Clinical trial
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid…
NCT00027872 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00027872 |
|---|---|
| Title | Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia |
| Official title | A Phase II Study of Farnesyl Transferase Inhibitor R115777 (Zarnestra) (R115777 ( Zarnestra), Tipifarnib, R115777, NSC #702818) in Elderly Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2) and 15 more |
| Intervention type | Drug, Other |
| Interventions | tipifarnib, laboratory biomarker analysis |
| Enrollment | 125 |
| Start date | Oct 1, 2001 |
| Primary completion | Jul 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: